The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease
Abstract
Parkinson's disease (PD), one of the most common movement and neurodegenerative disorders, is challenging to treat, largely because the blood-brain barrier blocks passage of most drugs. Here we find exosomes from blood showing natural brain targeting ability which involved the transferrin-transferrin receptor interaction. Thus, we develop a biocompatible platform based on blood exosomes for delivering drugs across the blood-brain barrier. Blood exosomes show sizes between 40 and 200 nm and spherical morphology, and dopamine can be efficiently loaded into blood exosomes by a saturated solution incubation method. Further in vitro and in vivo studies demonstrates these exosomes successfully delivered dopamine to brain, including the striatum and substantia nigra. Brain distribution of dopamine increased >15-fold by using the blood exosomes as delivery system. Dopamine-loaded exosomes show much better therapeutic efficacy in a PD mouse model and lower systemic toxicity than free dopamine after intravenous administration. These results suggest that blood exosomes can be used as a promising drug delivery platform for targeted therapy against PD and other diseases of the central nervous system.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a mouse Parkinson’s disease (PD) model, exosomes with pre-loaded dopamine exhibited better performance than free dopamine after intravenous injection [74].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [74]
Citations
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Pan, B., & Johnstone, R. M. (1983) · Cell · doi:10.1016/0092-8674(83)90040-5 · Cited by 2,042
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,841
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,674
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W. E., Miller, D., & Zhang, H. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,579
Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Kim, M. S., Haney, M. J., Zhao, Y., Mahajan, V., Deygen, I., Klyachko, N. L., Inskoe, E., Piroyan, A., Sokolsky, M., Okolie, O., et al. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.10.012 · Cited by 1,410
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 543
Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
Zhang, P., Rasheed, M., Liang, J., Wang, C., Feng, L. P., & Chen, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819836 · Cited by 19
Ansarey, S. H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.771144 · Cited by 21
Rademacher, D. J. (2023) · Biomedicines · doi:10.3390/biomedicines11041187 · Cited by 18
MicroRNA-23a-3p Is Upregulated in Plasma Exosomes of Bulbar-onset ALS Patients and Targets ERBB4
Liu, Y., Ding, M., Pan, S., Zhou, R., Yao, J., Fu, R., Yu, H., & Lu, Z. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.05.030 · Cited by 18
Extracellular Vesicles in Malaria: Shedding Light on Pathogenic Depths
Dey, S., Mohapatra, S., Khokhar, M., Hassan, S., & Pandey, R. K. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00649 · Cited by 21
Goldschmidt‐Clermont, P. J., Khan, A., Jimsheleishvili, G., Graham, P., Brooks, A. E., Silvera, R., Goldschmidt, A. J. P., Pearse, D. D., Dietrich, W. D., Levi, A. D., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01815 · Cited by 18
Cheng, W., Ren, W., Ye, P., Li, H., Bao, D., Yue, T., Lai, J., Wu, Y., Wei, Y., Wu, Z., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122702 · Cited by 19
Banerjee, A., Lino, M. M., Jesus, C., Ribeiro, Q., Abrunhosa, A., & Ferreira, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.06.039 · Cited by 18
Rajizadeh, M. A., Motamedy, S., Mir, Y., Akhgarandouz, F., Nematollahi, M. H., & Nezhadi, A. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105011 · Cited by 17
Chao, T., Zhao, J., Gao, R., Wang, H., Guo, J., Gao, Z., & Wang, Y. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00025 · Cited by 21
Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases
Hassanzadeh-khanmiri, M., Moshari, A., Kheradmand, R., Haghgouei, T., Homaei, M., Charsouei, S., & Mobed, A. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01564-3 · Cited by 17
Tang, X., He, Y., Liu, J., Xu, J., & Peng, Q. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113938 · Cited by 17
Sun, Y., Du, L., Yang, M., Li, Q., Jia, X., Li, Q., Zhu, L., Zhang, Y., Liu, Y., & Liu, S. (2021) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2021.07.003 · Cited by 18
Mesenchymal Cell-Derived Exosomes as Novel Useful Candidates for Drug Delivery
Einabadi, M., Ai, J., Kargar, M., Kafilzadeh, F., Nooshabadi, V. T., & Jamali, H. (2020) · Archives of Neuroscience · doi:10.5812/ans.98722 · Cited by 16
Pramoda, G., Verma, R. K., Kesharwani, P., & Shukla, R. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127938 · Cited by 15
The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease
Daksh, R., Mathew, M. S., Bosco, A. M., Sojan, C., Tom, A. A., Bojja, S. L., & Nampoothiri, M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151526 · Cited by 16
Liu, X.-C., Tian, J.-W., Xu, J., Chen, L., Ye, Z., Huang, J., Wu, L., Zhang, Z., Yu, Z., & Chen, G. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.06.020 · Cited by 16
Self-citationModern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics
Fedorova, O. V., Ovchinnikova, I. G., Rusinov, G. L., Avdeeva, V. V., Zhdanov, А. P., Zhizhin, K. Y., Kuznetsov, N. T., Zakharova, L. Y., Kuznetsova, D. A., Razuvayeva, Y. S., et al. (2025) · Russian Journal of General Chemistry · doi:10.1134/s1070363225606726 · Cited by 16
Deciphering the Role of Nanoparticle-based Treatment for Parkinson’s Disease
Moni, M. M. R., Begum, M. M., Uddin, M. S., & Ashraf, G. M. (2021) · Current Drug Metabolism · doi:10.2174/1389200222666210202110129 · Cited by 15
Miao, X., Tian, Y., Wu, L., Zhao, H., Liu, J., Gao, F., Zhang, W., Liu, Q., Guo, H., Yang, L., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00788-6 · Cited by 15
Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases
Bhosale, A., Paul, G., Mazahir, F., & Yadav, A. K. (2022) · OpenNano · doi:10.1016/j.onano.2022.100111 · Cited by 15
Wang, Z., Zheng, Y., Cai, H., Yang, C., Li, S., Lv, H., Feng, T., & Yu, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1170663 · Cited by 16
Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy
Yin, T., Liu, Y., He, B., Gong, B., Chu, J., Gao, C., Liang, W., Hao, M., Sun, W., Zhuang, J., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100789 · Cited by 16
Microglial exosomes in paraquat-induced Parkinson's disease: Neuroprotection and biomarker clues
Wu, J., Shao, W., Liu, X., Zheng, F., Wang, Y., Cai, P., Guo, Z., Hu, H., Yu, G., Guo, J., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124035 · Cited by 16
Zhu, Y., Wang, F., Xia, Y., Wang, L., Lin, H., Zhong, T., & Wang, X. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0043 · Cited by 15
Self-citationAshique, S., Kumar, N., Mishra, N., Muthu, S., Rajendran, R. L., Chandrasekaran, B., Obeng, B. F., Hong, C. M., Krishnan, A., Ahn, B., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155451 · Cited by 16
Wu, J., Li, A., Shi, Y., Wang, Y., Luo, J., Zhuang, W., Ma, X., Qiao, Z., Xiu, X., Lang, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113853 · Cited by 19
Sabnam, S., Kumar, R., & Tiwari, P. (2025) · Biomaterials Science · doi:10.1039/d5bm00179j · Cited by 15
Li, C., Wang, G., Ma, X., Tao, T., Li, Q., Yang, Y., Sang, H., & Wang, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2026727 · Cited by 15
Parkinson's Disease: Current Status, Diagnosis, and Treatment Using Nanomedicines
Hasan, I., Roy, S., Guo, B., & Chang, C. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300058 · Cited by 14
Nature vs. Manmade: Comparing Exosomes and Liposomes for Traumatic Brain Injury
Hennigan, K., & Lavik, E. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00849-8 · Cited by 14
Nishimura, K., Sanchez‐Molano, J., Kerr, N. A., Pressman, Y., Silvera, R., Khan, A., Gajavelli, S., Bramlett, H. M., & Dietrich, W. D. (2024) · Journal of Neurotrauma · doi:10.1089/neu.2023.0650 · Cited by 14
Chen, C.-Y., Wang, Y., Lei, L., & Zhang, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111186 · Cited by 14
Lazar, S. V., Mor, S., Wang, D., Goldbloom‐Helzner, L., Clark, K. C., Hao, D., Farmer, D. L., & Wang, A. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1541 · Cited by 14
Therapeutic potential of extracellular vesicles in neurodegenerative disorders
Roudi, S., Rädler, J., & Andaloussi, S. E. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00017-5 · Cited by 14
Kang, M., Blenkiron, C., & Chamley, L. W. (2023) · Clinical Science · doi:10.1042/cs20220301 · Cited by 14
Liang, Y., Feng, L., Zheng, Y., Gao, Y., Shi, R., Zhang, Z., Ying, X., & Zeng, Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s483595 · Cited by 13
Self-citationStem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
Zeng, X., & Qin, H. (2022) · Aging and Disease · doi:10.14336/ad.2022.0312 · Cited by 13
Extracellular vesicles‐based theranostics for neurodegenerative diseases
Zhao, H., Zhu, L., Wang, C., & Yang, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1993 · Cited by 14
Membrane vesicles nanotheranostic systems: sources, engineering methods, and challenges
Nie, W., Wu, G., Zhong, H., & Xie, H. (2020) · Biomedical Materials · doi:10.1088/1748-605x/abd2c8 · Cited by 14
Pfeiffer, P., Coates, J. R., Esqueda, Y. M., Kennedy, A., Getchell, K., McLenon, M., Kosa, E., & Aǵbaş, A. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2153162 · Cited by 13
Deng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 14
Kirit, E., Gokce, C., Altun, B., & Yılmazer, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c02206 · Cited by 13
Bukke, S. P. N., Yadav, S., Prajapati, S., Rani, S. S., Reddy, M. S., Thalluri, C., Chettupalli, A. K., Goruntla, N., Pradeepkumar, B., Eftekhari, Z., et al. (2025) · Tissue Barriers · doi:10.1080/21688370.2025.2607157 · Cited by 12
Exosomes and MicroRNAs in Biomedical Science
Mirzaei, H., Rahimian, N., Mirzaei, H. R., Nahand, J. S., & Hamblin, M. R. (2022) · Synthesis lectures on biomedical engineering · doi:10.2200/s01171ed1v01y202202bme062 · Cited by 27
Ilvonen, P., Pusa, R., Härkönen, K., Laitinen, S., & Impola, U. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.130 · Cited by 12
Jiyah, A., Muhammad, S. A., Ibrahim, A., Bulama, I., Ibrahim, A., Abbas, A. Y., Imam, M. U., Saidu, Y., & Bilbis, L. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105618 · Cited by 13
Role of miRNAs in neurovascular injury and repair
Sawant, H., Sun, B., Mcgrady, E., & Bihl, J. C. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241254772 · Cited by 12
Qin, J., Yuan, H., An, X., Liu, R., & Meng, B. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578403 · Cited by 13
Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease
Chawla, S., Kalyane, D., Tambe, V., Deb, P. K., Kalia, K., & Tekade, R. K. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.12.005 · Cited by 12
Bioengineering exosomes for treatment of organ ischemia-reperfusion injury
Toghiani, R., Abolmaali, S. S., Najafi, H., & Tamaddon, A. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120654 · Cited by 12
Хаспеков, Л. Г., & Yakovlev, A. A. (2023) · Neurochemical Journal · doi:10.1134/s1819712423010087 · Cited by 12
Kumar, B., Pandey, M., Fayaz, F., Izneid, T. A., Pottoo, F. H., Manchanda, S., Sharma, A., & Sahoo, P. K. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666201019112557 · Cited by 11
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 11
Unlocking mRNA-driven CRISPR-Cas9 gene therapy via optimizing mRNA and the delivery vectors
Wang, S., Xu, X., Viitala, T., Shu, Y., & Zhang, H. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102737 · Cited by 14
The emerging role of exosomes in Schizophrenia
Dai, J., Zhang, M., He, Q., & Chen, R. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115394 · Cited by 11
Cai, L., Wang, J., Xue, Y., Yu, S., Wang, C., Zhang, L., Zhang, X., Cheng, L., Ruan, W., Dong, F., et al. (2024) · Pediatric Research · doi:10.1038/s41390-024-03024-7 · Cited by 11
Self-citationCerebral biomimetic nano-drug delivery systems: A frontier strategy for immunotherapy
Tian, H., Yao, J., Ba, Q., Meng, Y., Cui, Y., Quan, L., Gong, W., Wang, Y., Yang, Y., Yang, M., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.058 · Cited by 12
Ali, I., Adil, M., Imran, M., Qureshi, S. A., Qureshi, S., Hasan, N., & Ahmad, F. J. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01799-8 · Cited by 11
Almasi, F., Abbasloo, F., Soltani, N., Dehbozorgi, M., Fard, A. M., Kiani, A., Ghasemzadeh, N., Mesgari, H., Hosseingholi, E. Z., Payandeh, Z., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04788-7 · Cited by 12
Zhang, S., Li, J., Hu, X., Liu, H., Yu, Q., Kuang, G., Liu, L., Yu, D., Lin, Z., & Xiong, N. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01262 · Cited by 14
Extracellular vesicles in regenerative medicine
Romano, M., Zendrini, A., Paolini, L., Busatto, S., Berardi, A. C., Bergese, P., & Radeghieri, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817838-6.00002-4 · Cited by 11
Inagaki, M., & Tachikawa, M. (2022) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00072 · Cited by 11
Dendrimers-Based Drug Delivery System: A Novel Approach in Addressing Parkinson’s Disease
Ordonio, M. B., Zaki, R. M., & Elkordy, A. (2022) · Future Pharmacology · doi:10.3390/futurepharmacol2040027 · Cited by 11
Exosomes transport trace amounts of (poly)phenols
Arola‐Arnal, A., Hazas, M. L. D. L., Iglesias‐Carres, L., Mantilla-Escalante, D. C., Suárez, M., Busto, R., Visioli, F., Bladé, C., & Dávalos, A. (2020) · Food & Function · doi:10.1039/d0fo01824d · Cited by 11
Lyu, Y., Guo, Y., Okeoma, C. M., Yan, Z., Hu, N., Li, Z., Zhou, S., Zhao, X., Li, J., & Wang, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114630 · Cited by 11
The Role of Extracellular Vesicles in Musculoskeletal Diseases
Fu, P., Luo, Y., Zheng, S., Ma, Z., Xiao, W., Li, H., & Li, Y. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70205 · Cited by 13
Exercise-mediated circulating metabolites for brain health
Wang, M., Nasb, M., Wu, T., Jia, M., & So, K. (2024) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2024.11.001 · Cited by 11
Zhu, A., Jiang, Y., Pan, L., Li, J., Huang, Y., Shi, M., Di, L., Wang, L., & Wang, R. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.013 · Cited by 10
Self-citationExploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases
Varshney, V., Gabble, B. C., Bishoyi, A. K., Varma, P., Qahtan, S. A., Kashyap, A., Panigrahi, R., Nathiya, D., & Chauhan, A. S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05026-w · Cited by 10
Kadbhane, A., Patel, M., Srivastava, S., Singh, P. K., Madan, J., Singh, S. B., & Khatri, D. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102526 · Cited by 10
Exploring the role of exosomes in rheumatoid arthritis
Singh, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Naqwi, M., Mavi, A. K., & Singh, R. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01100-0 · Cited by 10
An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis
Wang, K., Shen, J., & Xu, Y. C. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.017 · Cited by 10
Exosomes: Biological Couriers with Transformative Messages
Yousef, M. H., & Abdelnaser, A. (2019) · Journal of Biomedicine · doi:10.7150/jbm.34611 · Cited by 10
Circulating Extracellular Vesicles Are Increased in Newly Diagnosed Celiac Disease Patients
Efthymakis, K., Bologna, G., Simeone, P., Pierdomenico, L., Catitti, G., Vespa, S., Milano, A., Bellis, D. D., Laterza, F., Pandolfi, A., et al. (2022) · Nutrients · doi:10.3390/nu15010071 · Cited by 9
Exosomes as biomarkers and therapeutic measures for ischemic stroke
Shi, Y., Wang, R., Wang, L., Liu, Q., Han, L., Duan, X., Zhang, Y., Shen, A.-Z., Peng, D., Chen, W., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175477 · Cited by 9
Self-citationThe Biology, Pathological Roles of Exosomes and Their Clinical Application in Parkinson’s Disease
Huang, J., Yuan, X., Chen, L., Hu, B., Wang, H., & Huang, W. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.09.001 · Cited by 9
Akbari‐Gharalari, N., Ghahremani‐Nasab, M., Naderi, R., Chodari, L., & Nezhadshahmohammad, F. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024023 · Cited by 10
Nikanfar, M., Avci, Ç. B., Khalilnezhad, A., Shahriyari, E., & Nourazarian, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05247-z · Cited by 10
Exosomes as a Nanotheranostic Platform in Brain Diseases
Kudpaje, M., Joghee, S., & Kumar, R. M. R. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70215 · Cited by 10
Tailored Extracellular Vesicles: Novel Tool for Tissue Regeneration
Li, L., Wu, P., Qian, H., Xu, W., Shi, H., & Jiang, J. (2022) · Stem Cells International · doi:10.1155/2022/7695078 · Cited by 9
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
Sharma, S., Rana, R., Prakash, P., & Ganguly, N. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04715-1 · Cited by 10
Bioinspired Approaches for Central Nervous System Targeted Gene Delivery
Kumar, J., Karim, A., Sweety, U. H., Sarma, H., Nurunnabi, M., & Narayan, M. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00842 · Cited by 9
Perspective in Nuclear Theranostics Using Exosome for the Brain
Hwang, D. W. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-018-00567-6 · Cited by 9
Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology
Roy, R., Paul, R. K., Bhattacharya, P., & Borah, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00070 · Cited by 10
Valdameri, G., Kita, D. H., Dutra, J. D. P., Gomes, D. L., Tonduru, A. K., Kronenberger, T., Gavinho, B., Rossi, I. V., de Carvalho, M. M., Pérès, B., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041259 · Cited by 8
D’Arrigo, D., Salerno, M., Marziani, L. D., Boffa, A., & Filardo, G. (2024) · Human Cell · doi:10.1007/s13577-024-01084-9 · Cited by 8
Spheroid-Exosome-Based Bioprinting Technology in Regenerative Medicine
Lee, H.-Y., & Lee, J. W. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15110345 · Cited by 10
Afzal, M., Hameed, H., Paiva‐Santos, A. C., Saleem, M., Hameed, A., & Ahmad, S. M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177199 · Cited by 8
Exosome-based platforms for treatment of multiple sclerosis
Zonouz, A. M., Rahbardar, M. G., & Alibolandi, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111256 · Cited by 9
Biological and Bioinspired Vesicles for Wound Healing: Insights, Advances and Challenges
Zhao, Y., Zhang, T., Zhao, G., Lu, J., Zhang, X., Lai, Y., Chen, Z., Ding, X., & Tai, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s522067 · Cited by 10
Extracellular vesicles as the drug delivery vehicle for gene-based therapy
Aquino, A. D., Rubinstein, A., Кудрявцев, И. В., Yakovlev, A. A., & Головкин, А. С. (2025) · Applied Physics Reviews · doi:10.1063/5.0255519 · Cited by 9
Salim, M. W., Zhang, W., Collins‐Praino, L. E., Wang, Y., & Care, A. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202504608 · Cited by 8
Gupta, A., Hall, D. C., Rapaport, J. A., & Paradise, C. R. (2023) · Advances in Cosmetic Surgery · doi:10.1016/j.yacs.2022.10.002 · Cited by 8
Therapeutic potential of extracellular vesicles in Parkinson’s disease
Teixeira, M. R., Alievi, A. L., da Costa, V. R., Pinto, J. R. D., & Araldi, R. P. (2023) · Exploration of neuroscience · doi:10.37349/en.2023.00016 · Cited by 8
Deregulation of exosomal miRNAs in rheumatoid arthritis patients
Hussain, M. Z., Haris, M. S., Rizwan, M., Ashraf, N. S., Arshad, M., & Mahjabeen, I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0289301 · Cited by 9
Alqarni, A., Jasim, S. A., Altalbawy, F. M. A., Kaur, H., Kaur, I., Rodriguez‐Benites, C., Deorari, M., Alwaily, E. R., Al‐Ani, A. M., & Redhee, A. H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23719 · Cited by 8
Moradi, H. R., Abdollahinezhad, S., & Heydarian, S. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.2.87 · Cited by 8
Dehnavi, S., Khodadadi, A., Asadirad, A., & Ghadiri, A. (2023) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.11.4.626 · Cited by 8
Ray, R., Chowdhury, S. G., & Karmakar, P. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109906 · Cited by 8
Metadata
- Authors
- Qu, M., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S., Fu, Y., Yang, S., Zhang, Z., Zhang, L., & Sun, X.
- Affiliations
- Sichuan University (CN)
- Corresponding author
- Zhang, Ling
- Sun, Xun
- ORCID
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 287
- Pages
- 156-166
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2888790211
- Cited by
- 543
- References
- 43
- Citations by year
- 2026: 44 · 2025: 72 · 2024: 106 · 2023: 99 · 2022: 81 · 2021: 63 · 2020: 48 · 2019: 27 · 2018: 3
- FWCI
- 12.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Graduate Student's Research and Innovation Fund of Sichuan University
- National Natural Science Foundation of China (81690261)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Parkinson's disease, blood exosomes, blood-brain barrier, transferrin receptor, brain targeting, striatum, substantia nigra, brain drug delivery, neurodegenerative disease treatment
- MeSH terms
- Animals, Brain, Dopamine, Drug Carriers, Parkinson Disease, Dopamine Agents, Drug Delivery Systems, Mice, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review